Debt isn’t always a dirty word in the world of startups. Yesterday I heard John Hoesley from Silicon Valley Bank give a brief presentation on venture debt as a funding mechanism for startups at a capital connections event hosted by BioOhio. He mentioned that SVB has seen an uptick in its venture debt business over […]
Commercializing new products in pediatrics comes with many challenges — among them that children make up a small percentage of the population but have very specialized needs. Hospitals, foundations and academic institutions in Ohio have really prioritized pediatric innovation over the past several years — but more on that in a separate post. Leaders at […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Several Ohio groups have joined together in an effort to promote the state’s biomedical industry with an organization they’re calling “We Work for Health Ohio.” Ohio becomes one of 16 states, which include Indiana and Pennsylvania, to have its own “We Work for Health” initiative, according to a statement from the new organization. We Work […]
The number of bioscience jobs in Ohio grew nearly 20 percent over the last decade, which stands in stark contrast to overall employment trends in the state. From 2000 to 2009, bioscience employment in the state grew to 62,500 workers. Overall employment in the state declined nearly 9 percent, or about 465,000 jobs, in that […]
Ohio ranked 10th among U.S. states in attracting research funding from the National Institutes of Health last year at $778 million.
BioOhio is a state-funded non-profit organization that represents and supports bioscience industry, research and education in Ohio. Scott Osborne, BioOhio's director of business development, said this to say about today's proposed changes to the U.S. Food and Drug Administration's 510(k) program.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The looming specter of an $8 billion budget deficit will cast its shadow over nearly everything that happens – or doesn't happen – in the Ohio legislature this year. But that won't stop key interest groups from throughout Ohio's healthcare community from pushing for (and against) prospective laws that they hold most (or least) dear.
When it comes to keeping smiles on the faces of Ohio's medical industry leaders, Governor-elect John Kasich's predecessor did him a big favor. It's called Ohio Third Frontier.
Sixty-two medical companies in Ohio have received grants or tax credits through a provision of this year's health reform law that's designed to fund the development of new therapies.
Continuing education company Bioforum Applied Knowledge Center Inc. has unveiled 14 training courses it'll offer throughout the rest of 2010 to Ohio pharmaceutical and medical device professionals.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Economic development group BioOhio has established a partnership with a similar Chinese organization that it hopes will lead to new business and research opportunities for Ohio life sciences companies. The pact with the Beijing Pharma and Biotech Center is designed to promote development of biomedical companies that will have offices, research and development facilities, and […]
The Biotechnology Industry Organization international convention returns to Chicago this week — a nod to the importance of pharmaceutical and therapeutic companies in Midwestern states like Ohio. Drugmaking has history in Ohio. From Procter & Gamble Pharmaceuticals (NYSE: PG) in Cincinnati (sold last year to Irish drug company Warner Chilcott), to generic drugmakers Ben Venue […]
Updated 10:11 a.m., April 1, 2010. The Ohio bioscience industry grew by several measures through the recent economic downturn, continuing its decade-long path from a promising opportunity to a global powerhouse, according to Tony Dennis, president and chief executive of BioOhio. “Ohio’s aggressive and sound investment strategies in the biosciences are delivering results in the […]
The Expo will feature more than 60 exhibitors covering all aspects of moving biomedical products from idea to market, including laboratory supplies, clinical trial support, contract manufacturing, product design and prototyping, marketing advice, regulatory and legal counsel, and more.
The nonprofit, state-sponsored group that has been charged with promoting electronic health records adoption in Ohio has received a $43 million federal grant. The grant to the Ohio Health Information Partnership comes from last year's federal stimulus act and is part of $1 billion in recently announced federal funding for health information technology.